Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Temsirolimus Plus Neratinib for Patients With Metastatic HER2-Amplified or Triple Negative Breast Cancer

Puma Biotechnology, Inc. · 2010
ClinicalTrials.gov · Datasets · License: Public Domain · 2010
Open Source ↗
breast-cancer
breast cancer, hki-272 (neratinib), temsirolimus (cci-779), her2-amplified, triple-negative, invasive adenocarcinoma, 10-005, nerlynx, pb-272, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 888078
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.